A carregar...
A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone
RATIONALE: Myasthenia gravis (MG) patients are at increased risk of COVID-19 infection and its complications due to chronic immunosuppression. COVID-19 infection can also increase the risk of myasthenia exacerbation. PATIENT CONCERNS: The patient presented with respiratory distress, fever and chills...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8104252/ https://ncbi.nlm.nih.gov/pubmed/33950951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000025701 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|